George Matcham
Director/Board Member presso INSTIL BIO, INC.
Patrimonio netto: 19 586 $ in data 31/03/2024
Profilo
George Matcham currently works at Instil Bio, Inc., as Independent Director from 2018.
Dr. Matcham also formerly worked at Chimeric Therapeutics Ltd.
(Australia), as Non-Executive Director from 2021 to 2023, Celgene Corp., as SVP-CAR T CMC & Technology Development from 2017 to 2018, and Celgene Cellular Therapeutics, as Chief Operating Officer.
Dr. Matcham received his graduate degree from the University of Cambridge and undergraduate degree and doctorate degree from the University of Cardiff.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 21/09/2023 | 1 000 800 ( 0.12% ) | 19 586 $ | 31/03/2024 | |
INSTIL BIO, INC.
-.--% | 14/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di George Matcham
| Società | Posizione | Inizio |
|---|---|---|
| INSTIL BIO, INC. | Director/Board Member | 01/09/2018 |
Precedenti posizioni note di George Matcham
| Società | Posizione | Fine |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Director/Board Member | 03/08/2023 |
| CELGENE | Corporate Officer/Principal | 01/06/2018 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The private company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Chief Operating Officer | - |
Formazione di George Matcham
| University of Cambridge | Graduate Degree |
| University of Cardiff | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The private company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
| Chimeric Therapeutics Ltd. (Australia) |
- Borsa valori
- Insiders
- George Matcham
